SR One Capital Management’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $70M | Hold |
4,012,903
| – | – | 15.18% | 2 |
|
|
2025
Q1 | $50.5M | Hold |
4,012,903
| – | – | 12.97% | 2 |
|
|
2024
Q4 | $42.3M | Hold |
4,012,903
| – | – | 10.32% | 2 |
|
|
2024
Q3 | $58.2M | Hold |
4,012,903
| – | – | 11.67% | 3 |
|
|
2024
Q2 | $34.1M | Hold |
4,012,903
| – | – | 10.69% | 3 |
|
|
2024
Q1 | $41M | Hold |
4,012,903
| – | – | 11.26% | 3 |
|
|
2023
Q4 | $22M | Hold |
4,012,903
| – | – | 9.23% | 2 |
|
|
2023
Q3 | $15.2M | Hold |
4,012,903
| – | – | 7.77% | 4 |
|
|
2023
Q2 | $26.9M | Hold |
4,012,903
| – | – | 11.59% | 4 |
|
|
2023
Q1 | $26.1M | Buy |
4,012,903
+1,003,226
| +33% | +$6.53M | 9.73% | 4 |
|
|
2022
Q4 | $25.7M | Buy |
+3,009,677
| New | +$25.7M | 9.37% | 3 |
|